Walleye Trading LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 112 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$258,912
-83.8%
12,748
-79.6%
0.00%
-100.0%
Q3 2022$1,600,000
+164.0%
62,400
+103.9%
0.01%
+150.0%
Q4 2021$606,000
-11.3%
30,600
-11.8%
0.00%0.0%
Q3 2021$683,000
+173.2%
34,700
+206.5%
0.00%
+100.0%
Q2 2021$250,000
+19.6%
11,323
+28.7%
0.00%0.0%
Q1 2021$209,000
-73.3%
8,800
-70.6%
0.00%
-75.0%
Q4 2020$782,000
+173.4%
29,900
+81.8%
0.00%
+100.0%
Q3 2020$286,000
-58.7%
16,447
-60.1%
0.00%
-60.0%
Q2 2020$693,000
+124.3%
41,200
+61.4%
0.01%
+150.0%
Q4 2019$309,000
+39.2%
25,524
+62.6%
0.00%
+100.0%
Q3 2019$222,000
-60.9%
15,693
-69.2%
0.00%
-80.0%
Q2 2019$568,000
+35.2%
50,900
+42.2%
0.01%
+66.7%
Q1 2019$420,000
+204.3%
35,800
+261.6%
0.00%
+200.0%
Q3 2018$138,000
-86.3%
9,900
-84.6%
0.00%
-80.0%
Q2 2018$1,008,000
-40.6%
64,100
-37.9%
0.01%
-50.0%
Q1 2018$1,698,000
+138.5%
103,200
+180.5%
0.01%
+233.3%
Q3 2017$712,000
+401.4%
36,785
+204.0%
0.00%
+200.0%
Q2 2017$142,000
-84.7%
12,100
-85.7%
0.00%
-85.7%
Q1 2017$928,000
+174.6%
84,700
+81.8%
0.01%
+250.0%
Q4 2016$338,000
+160.0%
46,600
+133.0%
0.00%
+100.0%
Q3 2016$130,000
+6400.0%
20,000
+4900.0%
0.00%
Q2 2016$2,0000.0%400
-20.0%
0.00%
Q4 2015$2,000
-75.0%
500
-75.0%
0.00%
Q3 2015$8,0002,0000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders